Methodological approaches and directions for the development of laboratory diagnostics of epidemic parotitis


DOI: https://dx.doi.org/10.18565/epidem.2025.15.4.89-93

Zamotaeva T.L., Cherkashin E.A., Mikheeva I.V., Akimkin V.G.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
In recent years, many countries have seen an increase in the incidence of epidemic parotitis, making it crucial to improve diagnostic methods. This review analyzes the current state of epidemic parotitis diagnostics, highlights the limitations of the current serological method, and substantiates the need to develop and implement new approaches and technologies in clinical practice. It emphasizes the advantages of molecular diagnostic methods for this disease and the characteristics of the pathogen itself, which play an important role in the development of new diagnostic solutions.

Literature


1. Михеева И.В., Лисукова Т.Е., Чекалина К.И. Эпидемический паротит: руководство для врачей под ред. В.И. Покровского. М: ООО МИА; 2009. 248 с.


Mikheeva I.V., Lisukova T.E., Chekalina K.I. (Mumps: A guide for doctors edited by V.I. Pokrovsky). Moscow: Medical Information Agency, 2009. 248 p. (In Russ.).


2. Gouma S., Koopmans M.P., van Binnendijk R.S. Mumps virus pathogenesis: Insights and knowledge gaps. Hum. Vaccin Immunother. 2016; 12(12): 3110-3112. DOI: 10.1080/21645515.2016.1210745


3. Агафоноа А.П., ред. Эпидемический паротит. Современные представления о возбудителе, клиника, диагностика, профилактика. Новосибирск: ЗАО «Медикобиологический Союз», 2007. 82 с.


Agafonov A.P., ed. (Mumps. Modern concepts of the pathogen, clinical features, diagnostics, prevention). Novosibirsk: Medicobiological Union, 2007. 82 p. (In Russ.).


4. Михеева И.В. Эпидемиологическая ситуация по эпидемическому паротиту в Российской Федерации в 1995-2016 гг. Эпидемиология и Вакцинопрофилактика 2017; 16(6): 47–53. DOI: 10.31631/2073-3046-2017-16-6-47-53


Mikheeva I.V. (The Epidemiological Situation of Mumps in the Russian Federation in 1995-2016). Epidemiology and Vaccinal Prevention 2017; 16(6): 47–53. (In Russ.). DOI: 10.31631/2073-3046-2017-16-6-47-53


5. Тураева Н.В., Фролов Р.А., Цвиркун О.В. Характеристика эпидемиологической ситуации по эпидемическому паротиту в мире на современном этапе. Эпидемиология и Вакцинопрофилактика 2021; 20(2): 74–82. DOI: 10.31631/2073-3046-2021-20-2-74-82


Turaeva N.V., Frolov R.A., Tsvirkun O.V. (Characteristics of the epidemiological situation of epidemic mumps in the world at the present stage). Epidemiology and Vaccinal Prevention 2021; 20(2): 74–82. (In Russ.). DOI: 10.31631/2073-3046-2021-20-2-74-82


6. Тагирова З.Г., Арбулиева Е.А., Магомедова С.А. Анализ заболеваемости эпидемическим паротитом в Республике Дагестан. Инфекционные болезни 2019; 17(3): 20–25. DOI: 10.20953/1729-9225-2019-3-20-25


Tagirova Z.G., Arbulieva E.A., Magomedova S.A. (Analysis of the incidence of mumps in the Republic of Dagestan). Infectious Diseases 2019; 17(3): 20–25. (In Russ.). DOI: 10.20953/1729-9225-2019-3-20-25


7. Lam E., Rosen J.B., Zucker J.R. Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity. Clin. Microbiol. Rev. 2020; 33: e00151-19. DOI: 10.1128/CMR.00151-19


8. Семериков В.В., Юминова Н.В., Постаногова Н.О., Софронова Л.В., Контаров Н.А. Эпидемический паротит в России: эпидемическая ситуация, основные задачи и пути решения. Эпидемиология и Вакцинопрофилактика 2019; 18(6): 75–80. DOI: 10.31631/2073-3046-2019-18-6-75-80


Semerikov V.V., Yuminova N.V., Postanogova N.O., Sofronova L.V., Kontarov N.A. (Epidemic mumps in Russia: epidemic situation, main tasks and solutions). Epidemiology and Vaccine Prevention 2019; 18(6): 75–80. (In Russ.). DOI: 10.31631/2073-3046-2019-18-6-75-80


9. Schoch C.L., Ciufo S., Domrachev M., Hotton C.L., Sivakumar K., Khovanskaya R. NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020: baaa062. DOI: 10.1093/database/baaa062


10. Marin M., Marlow M., Moore K.L. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morb. Mortal Wkly Rep. 2018; 67(1): 33–38. DOI: 10.15585/mmwr.mm6701a7


11. Wu H., Wang F., Tang D., Mumps Orchitis: Clinical Aspects and Mechanisms. Front Immunol. 2021; (12): 582946. DOI: 10.3389/ fimmu.2021.582946


12. Forgione R.E., Di Carluccio C., Kubota M. Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase. Sci. Rep. 2020; 10(1): 1589. DOI: 10.1038/s41598-020-58559-6


13. Patel A.R., Garg A., Rosberger H.T., Kowdle S. Alveolar macrophages are early targets of mumps virus. Proc. Natl. Acad. Sci. USA. 2024; 121(52): e2410954121. DOI: 10.1073/pnas.2410954121


14. Russell R.R., Donald J.C. The neurological complications of mumps. Br. Med. J. 1958; 2(5087): 27–30. DOI: 10.1136/bmj.2.5087.27


15. Shepersky L., Marin M., Zhang J.. Mumps in Vaccinated Children and Adolescents: 2007–2019. Pediatrics 2021; 148(6): e2021051873. DOI: 10.1542/peds.2021-051873


16. Defendi G.L., Demirci C.S., Abuhammour W. Mumps. Medscape. 2025. https://emedicine.medscape.com/article/966678-overview


17. Agarwal R., Saxena A., Grover M. Atypical Mumps; are We Heading Towards an Outbreak? Indian J. Otolaryngol. Head Neck. Surg. 2024; 76(5): 4138–4145. DOI: 10.1007/s12070-024-04802-9


18. Choudhary S., Vaddi S.P., Sharma A.K. Acute Hydrocephalus Caused by Mumps Meningoencephalitis Mimicking Tubercular Meningitis: A Report of Two Cases. Pediatr. Infect. Dis. J. 2025; 44(2): e66. DOI: 10.1097/INF.0000000000004556


19. Rausch-Phung E.A., Davison P., Morris J. Mumps. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025.


20. WHO. Mumps: Vaccine Preventable Diseases Surveillance Standards. 2018. https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-mumps


21. Семериков В.В., Софронова Л.В., Постаногова Н.О. Стандартное определение клинического случая эпидемического паротита и диагностическая эффективность применяемых тест-систем в современный период. Журнал микробиологии, эпидемиологии и иммунобиологии. 2023; 100(1): 65–73. DOI: 10.36233/0372-9311-340


Semerikov V.V., Sofronova L.V., Postanogova N.O. (Standard definition of a clinical case of epidemic mumps and diagnostic efficiency of the test systems used in the modern period). Journal of Microbiology, Epidemiology and Immunobiology 2023; 100(1): 65–73. (In Russ.). DOI: 10.36233/0372-9311-340


22. Poggio G.P., Rodriguez C., Cisterna D. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J. Clin. Microbiol. 2000; 38(1): 274–278. DOI: 10.1128/JCM.38.1.274-278.2000.


23. Okafuji T., Yoshida N., Fujino M. Rapid diagnostic method for detection of mumps virus genome by loop-mediated isothermal amplification. J. Clin. Microbiol. 2005; 43(4): 1625–1631. DOI: 10.1128/JCM.43.4.1625-1631.2005


24. Кулак М.В., Белавин П.А., Нетесова Н.А. Дифференциация вакцинного штамма Л-3 от других штаммов вируса паротита методом ПЦР. Биопрепараты 2008; 4(32): 7–10.


Kulak M.V., Belavin P.A., Netesova N.A. (Differentiation of the vaccine strain L-3 from other strains of the mumps virus by the PCR method). Biopreparations 2008; 4(32): 7–10 (In Russ.).


25. Cui A., Rivailler P., Zhu Z., Deng X., Hu Y., Wang Y. et al. Evolutionary analysis of mumps viruses of genotype F colleted in mainland China in 2001–2015. Sci. Rep. 2017; 7(1): 17144. DOI: 10.1038/s41598-017-17474-z


26. Liu J.J., Teng L.P., Hua C.Z., Xie Y.P., Pan Y.X., Hu B.F. Etiological Analysis of Viral Encephalitis in Children in Zhejiang Province from 2018 to 2019. Diagnostics (Basel) 2022; 12(8): 1964. DOI: 10.3390/diagnostics12081964


About the Autors


Tatiana L. Zamotaeva, Researcher, Center for Product, Development and Innovation, Central Research Institute of Epidemiology. Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; zamotaevatat@gmail.com; http://orcid.org/0009-0003-9799-3749
Evgeny A. Cherkashin, Cand. Chim. Sci., Head, Center for Product, Development and Innovation, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e.cherkashin@pcr.ms; http://orcid.org/0000-0002-3627-6047
Professor Irina V. Mikheeva, MD, Head, Laboratory of Immunoprophylaxis, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; irina_mikheeva@mail.ru; https://orcid.org/0000-0001-8736-4007
Professor Vasily G. Akimkin, Academician of the Russian Academy of Sciences, MD, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; vgakimkin@yandex.ru; http://orcid.org/0000-0003-4228-9044


Similar Articles


Бионика Медиа